Skip to content
  • Friday, 14 August 2026
  • 10:22 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Ultraheavy Particles May Solve the Mystery of Ultrahigh-Energy Cosmic Rays
Advanced Materials Science

Ultraheavy Particles May Solve the Mystery of Ultrahigh-Energy Cosmic Rays

Nila Kartika Wati Jun 23, 2026 0

The discovery of the Amaterasu particle in 2021 sent shockwaves through the global astrophysical community, marking one of the most…

Read More
Advanced Materials Science

Ultraheavy Atomic Nuclei May Solve the Longstanding Mystery of Ultrahigh Energy Cosmic Rays and the Amaterasu Particle

Nila Kartika Wati Jun 15, 2026 0

The detection of the Amaterasu particle in 2021 sent shockwaves through the global astrophysical community, marking one of the most…

Read More
Recordati Weighs CVC’s €10.9 Billion Acquisition Offer, Potentially Delisting from Italian Stock ExchangeScientists turn brain cells into Alzheimer’s plaque cleanersBeyond the Neuron: Astrocytes Emerge as Crucial Regulators of Appetite and Satiety in Breakthrough Neuroscience StudyPrenatal Estrogen Exposure and the Evolution of the Human Brain: Insights from Digit Ratio and Neonatal Head Circumference
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ